Liquidia Corp. (LQDA)
42.65
+2.96
(+7.46%)
USD |
NASDAQ |
Oct 23, 16:00
42.25
-0.40
(-0.94%)
After-Hours: 20:00
Liquidia Price : 42.65 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 39.86 | 42.83 | 38.69 | 42.65 | 3.806M |
| Oct 22, 2026 | 38.75 | 40.08 | 38.22 | 39.69 | 3.534M |
| Oct 21, 2026 | 36.65 | 39.20 | 36.51 | 38.86 | 3.885M |
| Oct 20, 2026 | 33.90 | 36.93 | 33.65 | 36.35 | 3.997M |
| Oct 19, 2026 | 34.42 | 36.82 | 33.76 | 34.13 | 3.028M |
| Oct 16, 2026 | 34.78 | 34.90 | 33.33 | 34.35 | 4.550M |
| Oct 15, 2026 | 34.93 | 35.80 | 32.20 | 34.78 | 7.225M |
| Oct 14, 2026 | 35.70 | 38.64 | 33.12 | 33.94 | 21.14M |
| Oct 13, 2026 | 27.04 | 27.40 | 26.13 | 26.81 | 7.653M |
| Oct 12, 2026 | 29.27 | 30.86 | 27.28 | 27.67 | 4.414M |
| Oct 09, 2026 | 27.06 | 28.53 | 26.66 | 27.38 | 3.617M |
| Oct 08, 2026 | 26.34 | 29.35 | 26.34 | 28.02 | 5.260M |
| Oct 07, 2026 | 25.55 | 27.33 | 24.59 | 26.68 | 6.988M |
| Oct 06, 2026 | 27.95 | 28.30 | 25.76 | 25.91 | 5.314M |
| Oct 05, 2026 | 28.07 | 28.48 | 25.92 | 27.64 | 7.760M |
| Oct 02, 2026 | 26.69 | 29.18 | 26.31 | 28.64 | 8.404M |
| Oct 01, 2026 | 23.96 | 28.10 | 22.31 | 27.99 | 21.57M |
| Sep 30, 2026 | 70.54 | 71.93 | 29.86 | 30.26 | 22.95M |
| Sep 29, 2026 | 72.49 | 73.14 | 68.74 | 70.69 | 1.533M |
| Sep 28, 2026 | 68.05 | 74.74 | 67.66 | 73.67 | 1.206M |
| Sep 25, 2026 | 71.60 | 71.80 | 67.54 | 68.43 | 967527.0 |
| Sep 24, 2026 | 67.04 | 71.41 | 66.75 | 70.95 | 1.027M |
| Sep 23, 2026 | 68.60 | 68.60 | 67.10 | 67.49 | 766175.0 |
| Sep 22, 2026 | 66.59 | 68.76 | 66.00 | 68.64 | 1.139M |
| Sep 21, 2026 | 67.18 | 67.41 | 65.74 | 66.43 | 1.010M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Harmony Biosciences Holdings, Inc. | 36.13 |
| United Therapeutics Corp. | 587.50 |
| Johnson & Johnson | 263.81 |
| Amneal Pharmaceuticals, Inc. | 20.38 |
| Pfizer Inc. | 30.03 |
Price Related Metrics
| PE Ratio | 31.26 |
| PS Ratio | 9.196 |
| Price to Book Value | 19.48 |
| Price to Free Cash Flow | 27.52 |
| Earnings Yield | 3.20% |
| Market Cap | 3.800B |
| Operating PE Ratio | 24.60 |
| Normalized PE Ratio | 31.26 |